165 related articles for article (PubMed ID: 15803365)
1. Pathology of breast cancer in women with constitutional CHEK2 mutations.
Huzarski T; Cybulski C; Domagała W; Gronwald J; Byrski T; Szwiec M; Woyke S; Narod SA; Lubiński J
Breast Cancer Res Treat; 2005 Mar; 90(2):187-9. PubMed ID: 15803365
[TBL] [Abstract][Full Text] [Related]
2. A deletion in CHEK2 of 5,395 bp predisposes to breast cancer in Poland.
Cybulski C; Wokołorczyk D; Huzarski T; Byrski T; Gronwald J; Górski B; Debniak T; Masojć B; Jakubowska A; van de Wetering T; Narod SA; Lubiński J
Breast Cancer Res Treat; 2007 Mar; 102(1):119-22. PubMed ID: 16897426
[TBL] [Abstract][Full Text] [Related]
3. Different CHEK2 germline mutations are associated with distinct immunophenotypic molecular subtypes of breast cancer.
Domagala P; Wokolorczyk D; Cybulski C; Huzarski T; Lubinski J; Domagala W
Breast Cancer Res Treat; 2012 Apr; 132(3):937-45. PubMed ID: 21701879
[TBL] [Abstract][Full Text] [Related]
4. Analysis of CHEK2 FHA domain in Czech patients with sporadic breast cancer revealed distinct rare genetic alterations.
Kleibl Z; Havranek O; Novotny J; Kleiblova P; Soucek P; Pohlreich P
Breast Cancer Res Treat; 2008 Nov; 112(1):159-64. PubMed ID: 18058223
[TBL] [Abstract][Full Text] [Related]
5. CHEK2-positive breast cancers in young Polish women.
Cybulski C; Górski B; Huzarski T; Byrski T; Gronwald J; Debniak T; Wokolorczyk D; Jakubowska A; Kowalska E; Oszurek O; Narod SA; Lubinski J
Clin Cancer Res; 2006 Aug; 12(16):4832-5. PubMed ID: 16914568
[TBL] [Abstract][Full Text] [Related]
6. Effect of CHEK2 missense variant I157T on the risk of breast cancer in carriers of other CHEK2 or BRCA1 mutations.
Cybulski C; Górski B; Huzarski T; Byrski T; Gronwald J; Debniak T; Wokolorczyk D; Jakubowska A; Serrano-Fernández P; Dork T; Narod SA; Lubinski J
J Med Genet; 2009 Feb; 46(2):132-5. PubMed ID: 18930998
[TBL] [Abstract][Full Text] [Related]
7. Synergistic interaction of variants in CHEK2 and BRCA2 on breast cancer risk.
Serrano-Fernández P; Debniak T; Górski B; Bogdanova N; Dörk T; Cybulski C; Huzarski T; Byrski T; Gronwald J; Wokołorczyk D; Narod SA; Lubiński J
Breast Cancer Res Treat; 2009 Sep; 117(1):161-5. PubMed ID: 19030985
[TBL] [Abstract][Full Text] [Related]
8. Correlation of CHEK2 protein expression and c.1100delC mutation status with tumor characteristics among unselected breast cancer patients.
Kilpivaara O; Bartkova J; Eerola H; Syrjäkoski K; Vahteristo P; Lukas J; Blomqvist C; Holli K; Heikkilä P; Sauter G; Kallioniemi OP; Bartek J; Nevanlinna H
Int J Cancer; 2005 Feb; 113(4):575-80. PubMed ID: 15472904
[TBL] [Abstract][Full Text] [Related]
9. CHEK2 variants predispose to benign, borderline and low-grade invasive ovarian tumors.
Szymanska-Pasternak J; Szymanska A; Medrek K; Imyanitov EN; Cybulski C; Gorski B; Magnowski P; Dziuba I; Gugala K; Debniak B; Gozdz S; Sokolenko AP; Krylova NY; Lobeiko OS; Narod SA; Lubinski J
Gynecol Oncol; 2006 Sep; 102(3):429-31. PubMed ID: 16828850
[TBL] [Abstract][Full Text] [Related]
10. Germline CHEK2 mutations in Jewish Ashkenazi women at high risk for breast cancer.
Laitman Y; Kaufman B; Lahad EL; Papa MZ; Friedman E
Isr Med Assoc J; 2007 Nov; 9(11):791-6. PubMed ID: 18085035
[TBL] [Abstract][Full Text] [Related]
11. Risk of breast cancer in women with a CHEK2 mutation with and without a family history of breast cancer.
Cybulski C; Wokołorczyk D; Jakubowska A; Huzarski T; Byrski T; Gronwald J; Masojć B; Deebniak T; Górski B; Blecharz P; Narod SA; Lubiński J
J Clin Oncol; 2011 Oct; 29(28):3747-52. PubMed ID: 21876083
[TBL] [Abstract][Full Text] [Related]
12. CHEK2 1100delC, IVS2+1G>A and I157T mutations are not present in colorectal cancer cases from Turkish population.
Bayram S; Topaktaş M; Akkız H; Bekar A; Akgöllü E
Cancer Epidemiol; 2012 Oct; 36(5):453-7. PubMed ID: 22521562
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor status in CHEK2-positive breast cancers: implications for chemoprevention.
Cybulski C; Huzarski T; Byrski T; Gronwald J; Debniak T; Jakubowska A; Górski B; Wokołorczyk D; Masojć B; Narod SA; Lubiński J
Clin Genet; 2009 Jan; 75(1):72-8. PubMed ID: 19021634
[TBL] [Abstract][Full Text] [Related]
14. Germline CHEK2 mutations and colorectal cancer risk: different effects of a missense and truncating mutations?
Cybulski C; Wokołorczyk D; Kładny J; Kurzawski G; Suchy J; Grabowska E; Gronwald J; Huzarski T; Byrski T; Górski B; D Ecedil Bniak T; Narod SA; Lubiński J
Eur J Hum Genet; 2007 Feb; 15(2):237-41. PubMed ID: 17106448
[TBL] [Abstract][Full Text] [Related]
15. CHEK2*1100delC genotyping for clinical assessment of breast cancer risk: meta-analyses of 26,000 patient cases and 27,000 controls.
Weischer M; Bojesen SE; Ellervik C; Tybjaerg-Hansen A; Nordestgaard BG
J Clin Oncol; 2008 Feb; 26(4):542-8. PubMed ID: 18172190
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer predisposing alleles in Poland.
Górski B; Cybulski C; Huzarski T; Byrski T; Gronwald J; Jakubowska A; Stawicka M; Gozdecka-Grodecka S; Szwiec M; Urbański K; Mituś J; Marczyk E; Dziuba J; Wandzel P; Surdyka D; Haus O; Janiszewska H; Debniak T; Tołoczko-Grabarek A; Medrek K; Masojć B; Mierzejewski M; Kowalska E; Narod SA; Lubiński J
Breast Cancer Res Treat; 2005 Jul; 92(1):19-24. PubMed ID: 15980987
[TBL] [Abstract][Full Text] [Related]
17. No increased susceptibility to breast cancer from combined CHEK2 1100delC genotype and the HLA class III region risk factors.
de Jong MM; Nolte IM; Te Meerman GJ; van der Graaf WT; Oosterom E; Bruinenberg M; Steege Gv; Oosterwijk JC; van der Hout AH; Boezen HM; Schaapveld M; Kleibeuker JH; de Vries EG
Eur J Cancer; 2005 Aug; 41(12):1819-23. PubMed ID: 16043347
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer in patients carrying a germ-line CHEK2 mutation: Outcome after breast conserving surgery and adjuvant radiotherapy.
Meyer A; Dörk T; Sohn C; Karstens JH; Bremer M
Radiother Oncol; 2007 Mar; 82(3):349-53. PubMed ID: 17250914
[TBL] [Abstract][Full Text] [Related]
19. A nonsense mutation (E1978X) in the ATM gene is associated with breast cancer.
Bogdanova N; Cybulski C; Bermisheva M; Datsyuk I; Yamini P; Hillemanns P; Antonenkova NN; Khusnutdinova E; Lubinski J; Dörk T
Breast Cancer Res Treat; 2009 Nov; 118(1):207-11. PubMed ID: 18807267
[TBL] [Abstract][Full Text] [Related]
20. A simple method of investigating mutations in CHEK2 by DHPLC: a study of the German populations of Saxony, Saxony-Anhalt, and Thuringia.
Scharrer U; Skrzypczak-Zielinska M; Wituszynska W; Mierzejewski M; Krause K; Cybulski C; Froster UG
Cancer Genet Cytogenet; 2010 May; 199(1):48-52. PubMed ID: 20417869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]